Dr. Jeffery Kocsis

Scientific Adviser

Dr. Jeff Kocsis (Yale University) has shown that mesenchymal stem cells derived from adult human bone marrow when transplanted into experimental demyelinating lesions, produce a significant improvement in functional outcome.  They do this by stimulating new myelin formation. Research Interests: Transplantation-based approaches toward restoration and preservation of function in the injured central nervous system; Axonal Regeneration; Cell Transplantation; Ion Channels; Nerve Injury; Remyelination; Spinal Cord Injury.